Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the safety, pharmacokinetics, and preliminary efficacy of MK-6204 (SKB535) for injection in participants with advanced solid tumors; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• MK-6204 (SKB535) (MK-6204)

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING